ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find

August 25, 2006

Cancer Meetings For May, June, Future

April 27, 1990

NCI Resources, Services Available For Cancer Research

June 7, 1996

Manville Sues U.S. Over “Withheld” Wartime Data

July 22, 1983

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002